Cizzle Biotechnology Holdings
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Cizzle Biotechnology Holdings generated cash of -$639,000, which is more than the previous year. Cash used in financing activities reached the amount of $305,000 last year. Net change in cash is therefore -$334,000.
Cash Flow
| 2014 | -526K | -776K | 1.83M |
|---|---|---|---|
| 2015 | -570K | -809K | 439K |
| 2016 | 186K | -854K | 696K |
| 2017 | -190K | -418K | 427K |
| 2018 | -513K | 225K | 248K |
| 2019 | -7.07K | 0 | 1.20M |
| 2020 | -294K | 0 | 10 |
| 2021 | -1.00M | -154K | 2.03M |
| 2022 | -872K | -120K | 595K |
| 2023 | -639K | 0 | 305K |
CIZ.L Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 478K | 875K | 7K | 378K | 19.88K | 44K | 225K | 197K | 1.13M | 603K |
Operating activities | ||||||||||
Net income | -1.76M | -963K | -3.95M | -306K | -21.70K | -2.17M | -2.07M | -1.43M | -3.02M | -1.53M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 0 | 0 | 0 | 0 | 624K | 668K | 640K | 717K | 579K |
Stock-based compensation expense | 307K | 148K | 310K | 0 | 0 | 0 | 39K | 42K | 3K | 72K |
| Deferred income tax benefit | 307K | 148K | 310K | 0 | 0 | 0 | 39K | 42K | 3K | 72K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -24K | 16K | 7K | 25K | 48K | 0 | 91K | 0 | -63K | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 761K | 13K | 100K | 185K | 112K |
Accounts payable | 0 | 0 | 0 | -13K | -46K | 0 | 137K | 0 | -406K | 0 |
Cash generated by operating activities | -639K | -872K | -1.00M | -294K | -7.07K | -513K | -190K | 186K | -570K | -526K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -120K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | -200K | 0 | 0 | -176K | -467K | -907K | -809K | -776K |
Acquisitions Net | 0 | 0 | 46K | 0 | 0 | 0 | 49K | 0 | 0 | 0 |
Cash generated by investing activities | 0 | -120K | -154K | 0 | 0 | 225K | -418K | -854K | -809K | -776K |
Financing activities | ||||||||||
Common Stock Issued | 305K | 595K | 2.04M | 0 | 1.20M | 1.08M | 425K | 907K | 122K | 2.07M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -34K |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -34K |
Repayments of term debt | 0 | 0 | -10K | 0 | 0 | -833K | 2K | -211K | 317K | -202K |
Cash used in financing activities | 305K | 595K | 2.03M | 10 | 1.20M | 248K | 427K | 696K | 439K | 1.83M |
Net Change In Cash | -334K | -397K | 868K | -294K | -7.07K | -40K | -181K | 28K | -940K | 534K |
Cash at end of period | 144K | 478K | 875K | 84K | 12.81K | 4K | 44K | 225K | 197K | 1.13M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |